The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study. (Q53112682)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 April 2013

edit

Language	Label	Description	Also known as
English	The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study.	scientific article published on 3 April 2013

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

title

The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

main subject

endometrial cancer

1 reference

based on heuristic

inferred from title

author

William David Foulkes

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

Jan Lubiński

series ordinal

3

object named as

Jan Lubinski

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

Susan L Neuhausen

series ordinal

12

object named as

Susan L Neuhausen

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

Steven A. Narod

series ordinal

17

object named as

Steven A Narod

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

Jacek Gronwald

series ordinal

4

object named as

Jacek Gronwald

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

Parviz Ghadirian

series ordinal

7

object named as

Parviz Ghadirian

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

Charmaine Kim-Sing

series ordinal

10

object named as

Charmaine Kim-Sing

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

Nadine M Tung

series ordinal

9

object named as

Nadine Tung

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

Leigha Senter

series ordinal

13

object named as

Leigha Senter

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

Pål Møller

series ordinal

6

object named as

Pal Moller

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

Beth Karlan

series ordinal

15

object named as

Beth Karlan

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

Yakir Segev

series ordinal

1

object named as

Yakir Segev

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

Hereditary Breast Cancer Study Group

series ordinal

18

object named as

Hereditary Breast Cancer Study Group

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

Christian F Singer

series ordinal

14

object named as

Christian F Singer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

author name string

Javaid Iqbal

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

Henry T Lynch

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

Barry Rosen

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

Sun Ping

series ordinal

16

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

language of work or name

English

0 references

publication date

3 April 2013

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

published in

Gynecologic Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

volume

130

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

page(s)

127-131

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

cites work

The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

Cancer Incidence in BRCA1 mutation carriers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

Cancer risks in BRCA2 mutation carriers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

Risk of Endometrial Carcinoma Associated with BRCA Mutation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

Tamoxifen and risk of endometrial cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

The risk of developing uterine sarcoma after tamoxifen use.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

Menopause, hormone replacement therapy and cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

Endometrial cancer and hormone-replacement therapy in the Million Women Study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

retrieved

7 January 2021

Identifiers

DOI

10.1016/J.YGYNO.2013.03.027

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

PubMed publication ID

23562522

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23562522

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/23562522

ResearchGate publication ID

236127261

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53112682&oldid=2270411929"